Company Filing History:
1 out of 3,684 
1 out of 41 Years Active: 2003-2007
Title: Franck Duclos: Innovator in Cysteine Proteases and Metalloproteases
Introduction
Franck Duclos is a notable inventor based in Washington Crossing, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotides and their applications in medical science. With a total of 2 patents, his work focuses on novel cysteine proteases and metalloproteases that have potential therapeutic implications.
Latest Patents
Duclos's latest patents include innovative polynucleotides encoding novel cysteine proteases of the calpain superfamily, specifically CAN-12v1 and CAN-12v2. These inventions provide polynucleotides that encode CAN-12 polypeptides, fragments, and homologues. Additionally, they encompass vectors, host cells, antibodies, and methods for producing these polypeptides. The inventions also relate to diagnostic and therapeutic methods for utilizing CAN-12 polypeptides in treating neuro- and musculo-degenerative conditions. Furthermore, Duclos has developed polynucleotides encoding a novel metalloprotease, MP-1, which also includes vectors and methods for production and application in various medical contexts.
Career Highlights
Throughout his career, Franck Duclos has worked with prominent companies, including Bristol-Myers Squibb Company. His experience in the pharmaceutical industry has allowed him to contribute to significant advancements in biotechnology and therapeutic development.
Collaborations
Duclos has collaborated with esteemed colleagues such as Jian Chen and Thomas C. Nelson. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Franck Duclos is a distinguished inventor whose work in polynucleotides and proteases holds promise for advancing medical diagnostics and treatments. His contributions to biotechnology continue to influence the field and pave the way for future innovations.